Clinical markers of vitiligo activity - 18/04/17
, Yvon Gauthier, MD bAbstract |
Background |
Current modalities of understanding disease state (active/stable) are limited when considering treatment of vitiligo.
Objective |
We sought to develop a rapid, accurate, and noninvasive assessment of vitiligo state.
Methods |
In daylight and Wood's light examinations, 2 common clinical types of vitiligo were identified as amelanotic with sharply demarcated borders and hypomelanotic with poorly defined borders. Photographs were taken at the time of examination and a skin biopsy at the edge of a vitiligo lesion was performed. One year after the initial visit, the vitiligo was classified as stable if no new lesions had appeared, and as active if the number, size, or both of existing vitiligo lesions were increased. Skin biopsy specimens from 71 patients were stained and immunostained for melanocytes, CD8+ T lymphocytes, and E-cadherin.
Results |
The active lesions were associated with hypomelanotic appearance with poorly defined borders (P < .001), and histologically with an infiltration of CD8+ T lymphocytes in the epidermis and dermis (P = .017), with a strong expression of E-cadherin (P = .044).
Limitation |
The fact that this was a single-center study and that activity was sometimes site-dependent are limitations.
Conclusion |
The hypomelanotic with poorly defined borders type could be a good indicator of the actual activity of a vitiligo lesion.
Le texte complet de cet article est disponible en PDF.Key words : activity, clinical aspect, histology, perilesional skin, vitiligo, Wood's light
Abbreviations used : ASDB, HPDB, RCM, VETF
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 76 - N° 5
P. 856-862 - mai 2017 Retour au numéro
Article précédent
- Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity
- James P. Strassner, Mehdi Rashighi, Maggi Ahmed Refat, Jillian M. Richmond, John E. Harris
- Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo
- Maiana Larsabal, Aurélie Marti, Clément Jacquemin, Jérôme Rambert, Denis Thiolat, Léa Dousset, Alain Taieb, Caroline Dutriaux, Sorilla Prey, Katia Boniface, Julien Seneschal
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?